Lu Xin Capital, the main shareholder of Sanyuan Biotech (301206.SZ), plans to reduce its holdings by no more than 3%

Zhitongcaijing · 10/16 12:57

Zhitong Finance App News, Sanyuan Biotech (301206.SZ) announced that Shandong Luxin Qisheng Investment Management Co., Ltd., the shareholder holding 5% or more of the company's shares - Shandong Luxin Capital Market Development Equity Investment Fund Partnership (limited partnership) (“Luxin Capital”) plans to reduce the total shares of the company's shares by no more than 6.056 million shares within 3 months (November 7, 2024 to February 6, 2025) within 3 months (November 7, 2024 to February 6, 2025) from the date of disclosure of this announcement (November 7, 2024 to February 6, 2025) 3% of share capital).